BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16227680)

  • 21. A case of natural killer cell leukemia misdiagnosed as tuberculous lymphadenopathy.
    Lee AJ; Kim SG; Jeon CH; Suh HS; Yoon GS; Seo AN
    Korean J Lab Med; 2009 Jun; 29(3):194-8. PubMed ID: 19571615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aggressive NK cell leukemia/lymphoma: an autopsy case].
    Takai K; Sanada M
    Rinsho Ketsueki; 2001 Aug; 42(8):621-6. PubMed ID: 11579501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma.
    Kimura S; Kakazu N; Kuroda J; Akaogi T; Hayashi H; Nishida K; Abe T
    Ann Hematol; 2001 Apr; 80(4):228-31. PubMed ID: 11401089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.
    Karube K; Ohshima K; Tsuchiya T; Yamaguchi T; Suefuji H; Suzumiya J; Harada M; Kikuchi M
    Am J Surg Pathol; 2003 Oct; 27(10):1366-74. PubMed ID: 14508398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia.
    Camera A; Pezzullo L; Villa MR; Luciano L; Pane F; Izzo B; Boccuni P; Di Noto R; Del Vecchio L; Salvatore F; Rotoli B
    Haematologica; 2000 May; 85(5):496-501. PubMed ID: 10800166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement.
    Aoyama Y; Yamane T; Hino M; Ohta K; Nakamae H; Yamamura R; Koh KR; Takubo T; Inoue T; Tatsumi Y; Tatsumi N
    Ann Hematol; 2001 Dec; 80(12):752-4. PubMed ID: 11797118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+/CD56+ hematodermic neoplasm: blastic NK cell lymphoma in a 6-year-old child: report of a case and review of literature.
    Eguaras AV; Lo RW; Veloso JD; Tan VG; Enriquez ML; Del Rosario ML
    J Pediatr Hematol Oncol; 2007 Nov; 29(11):766-9. PubMed ID: 17984695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+CD56+ lineage negative hematopoietic neoplasm: so called blastic NK cell lymphoma.
    Kim Y; Kang MS; Kim CW; Sung R; Ko YH
    J Korean Med Sci; 2005 Apr; 20(2):319-24. PubMed ID: 15832009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.
    Suzuki R; Suzumiya J; Nakamura S; Aoki S; Notoya A; Ozaki S; Gondo H; Hino N; Mori H; Sugimori H; Kawa K; Oshimi K;
    Leukemia; 2004 Apr; 18(4):763-70. PubMed ID: 14961041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Retrospective analysis of 4 cases of the so-called blastic NK-cell lymphoma, with reference to the 2008 WHO classification of tumours of haematopoietic and lymphoid tissues].
    Zheng YY; Chen G; Zhou XG; Jin Y; Xie JL; Zhang SH; Zhang YN
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):600-5. PubMed ID: 21092587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphoblastic lymphoma of natural killer cell origin, presenting as pancreatic tumour.
    Tamura H; Ogata K; Mori S; An E; Tajika K; Sugisaki Y; Dan K
    Histopathology; 1998 Jun; 32(6):508-11. PubMed ID: 9675589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal CD56 positive small round cell tumors. Differential diagnosis of hematological, neurogenic, and myogenic neoplasms.
    Liu Q; Ohshima K; Sumie A; Suzushima H; Iwasaki H; Kikuchi M
    Virchows Arch; 2001 Mar; 438(3):271-9. PubMed ID: 11315624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
    DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
    Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blastic natural killer cell lymphoma/leukemia: a report of seven cases.
    Bayerl MG; Rakozy CK; Mohamed AN; Vo TD; Long M; Eilender D; Palutke M
    Am J Clin Pathol; 2002 Jan; 117(1):41-50. PubMed ID: 11789729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a myeloperoxidase mRNA(+) acute lymphoblastic leukemia cell line (EU-1/ALL) established from a child with an apparent case of ALL.
    Zhou M; Zaki SR; Ragab AH; Findley HW
    Leukemia; 1994 Apr; 8(4):659-63. PubMed ID: 8152261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell/natural killer cell lymphoblastic lymphoma with an unusual coexpression of B-cell antigens.
    Gloeckner-Hofmann K; Ottesen K; Schmidt S; Nizze H; Feller AC; Merz H
    Ann Hematol; 2000 Nov; 79(11):635-9. PubMed ID: 11131924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
    Owatari S; Otsuka M; Takeshita T; Mizukami K; Suzuki S; Uozumi K; Tashiro Y; Arima N; Hanada S
    Int J Hematol; 2009 Mar; 89(2):188-194. PubMed ID: 19109730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.